Patents by Inventor Ami TAMIR

Ami TAMIR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240076346
    Abstract: Type I membrane proteins heterodimers are provided. Accordingly, there is provided a heterodimer comprising two polypeptides selected from the group consisting of SIRPalpha, PD1, TIGIT, LILRB2 and SIGLEC10, wherein each of the two polypeptides is capable of binding a natural binding pair thereof, and wherein the heterodimer does not comprise an amino acid sequence of a type II membrane protein capable of binding a natural binding pair thereof. Also provided are nucleic acid constructs and systems encoding the heterodimer, host-cells expressing same and methods of use thereof.
    Type: Application
    Filed: January 13, 2021
    Publication date: March 7, 2024
    Applicants: KAHR Medical Ltd., Thomas Jefferson University
    Inventors: Ami TAMIR, Mark L. TYKOCINSKI, Edwin BREMER
  • Publication number: 20220267409
    Abstract: Heterodimers are provided. Accordingly, there is provided a heterodimer comprising a dimerizing moiety attached to at least one amino acid sequence of at least one type I membrane protein capable of at least binding a natural ligand or receptor of said at least one type I membrane protein and to at least one amino acid sequence of at least one type II membrane protein capable of at least binding a natural ligand or receptor of said at least one type II membrane protein. Also provided are nucleic acid constructs and systems encoding the heterodimer, host-cells expressing same and methods of use thereof.
    Type: Application
    Filed: July 8, 2020
    Publication date: August 25, 2022
    Applicants: KAHR Medical Ltd., Thomas Jefferson University
    Inventors: Mark L. TYKOCINSKI, Ami TAMIR, Edwin BREMER